|
Volumn 38, Issue 11, 2008, Pages 2927-2929
|
NK cells: New issues and challenges
|
Author keywords
Cellular immunology; Immunotheraphy; NK cells
|
Indexed keywords
CYCLOPHOSPHAMIDE;
GAMMA INTERFERON;
GRANZYME B;
HISTONE DEACETYLASE INHIBITOR;
IMMUNOGLOBULIN;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
NATURAL KILLER CELL RECEPTOR NKG2D;
PERFORIN;
TUMOR NECROSIS FACTOR ALPHA;
NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;
UNCLASSIFIED DRUG;
ADAPTIVE IMMUNITY;
ANTIGEN BINDING;
AUTOIMMUNITY;
BINDING AFFINITY;
CANCER IMMUNOTHERAPY;
CANCER THERAPY;
CELL FUNCTION;
CELL INTERACTION;
DENDRITIC CELL;
DRUG EFFICACY;
EDITORIAL;
EFFECTOR CELL;
GENETIC POLYMORPHISM;
HUMAN;
IMMUNOSURVEILLANCE;
INFECTION;
INNATE IMMUNITY;
NATURAL KILLER CELL;
NONHUMAN;
PATHOGENICITY;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE ACTIVATION;
TH1 CELL;
TUMOR;
TUMOR IMMUNITY;
ANIMAL;
IMMUNOLOGY;
NEOPLASM;
PHYSIOLOGY;
VIRUS INFECTION;
ANIMALS;
HUMANS;
KILLER CELLS, NATURAL;
NEOPLASMS;
NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;
VIRUS DISEASES;
|
EID: 58149333335
PISSN: 00142980
EISSN: 15214141
Source Type: Journal
DOI: 10.1002/eji.200838883 Document Type: Editorial |
Times cited : (11)
|
References (26)
|